MINNEAPOLIS -- June 3, 2013 -- Continuing to demonstrate its ongoing commitment to advancing interventional treatments of peripheral artery disease and the evidence to support their adoption, Medtronic, Inc. (NYSE: MDT) announced today that enough ...

MINNEAPOLIS -- May 30, 2013 -- Medtronic, Inc. (NYSE: MDT) is expanding its market-leading portfolio of products for endovascular aortic repair in the United States with two new medical devices: the company recently received approval from the U.S.

MINNEAPOLIS - May 24, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the.

MINNEAPOLIS - May 23, 2013 - Medtronic, Inc. (NYSE: MDT) today announced it has received Conformit� Europ�enne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve� and CoreValve� Evolut(TM) transcatheter aortic valve implantation ...

PARIS -- May 22, 2013 -- Addressing one of the most common clinical challenges in the treatment of complex coronary artery disease, three separate analyses on the program for EuroPCR this week show how strongly the Resolute drug-eluting stent from ...

MINNEAPOLIS and PARIS - MAY 21, 2013 - Medtronic, Inc. (NYSE: MDT), announced today the first results from the Global SYMPLICITY Registry, which reaffirmed the safety of the renal denervation procedure with the Symplicity(TM) renal denervation ...

MINNEAPOLIS - May 23, 2013 - Medtronic, Inc. (NYSE: MDT), today announced it has finished randomizing Symplicity HTN-3, the company's pivotal U.S.

PARIS -- May 23, 2013 -- One-year data from an Italian multicenter randomized controlled trial of the IN.PACT Falcon drug-eluting balloon from Medtronic, Inc. (NYSE: MDT) demonstrate positive and durable clinical results with the novel angioplasty ...

(RTTNews.com) - Medtronic Inc. ( MDT ) reported first quarter non-GAAP EPS of $1.10 Tuesday morning, up from $0.99 a year ago.

NuVasive Inc. (>> NuVasive, Inc.) will raise its estimated litigation royalty expense for the year and also record a charge in the current quarter following a U.S.